Health Condition 1: E08-E13- Diabetes mellitus
Conditions
Interventions
None listed
Sponsors
Bharati Vidyapeeth DU Medical College and Hospital
Eligibility
Inclusion criteria
Inclusion criteria: Age more than 18 years HbA1c between 6.5 to 8 percent Patient on the stable anti-diabetic medication for at least three months
Exclusion criteria
Exclusion criteria: Patients receiving anti-inflammatory drugs for chronic inflammatory disorder except low dose aspirin Presence of fever in preceding three weeks requiring antibiotics or infectious diseases with CRP more than 30mg dL or H O recurrent infections Anaemia (Hb less than 5Gms percent) Neutropenia (WBC count less than 200 per ml) Pregnancy or breast feeding Liver disease AST or ALT levels more than three times normal Kidney disease S creatinine more than 1.5mg percent Known patient of endocrine disorders other than T2DM Known patient of malignancy Known patient of Cardiac dysfunction arrhythmias or cardiac failure Known patient of Chronic Respiratory Diseases Known patient of demyelinating disease Patient who has participated in any other drug trial in 30 days Patient who has undergone major surgery in 30 days
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: NIL | — |
Primary
| Measure | Time frame |
|---|---|
| Nisha amalaki is expected to have anti oxidant and anti inflammatory action along with add on effect on glycemic and lipid levelsTimepoint: 0 to 36 months | — |
Countries
India
Contacts
Public ContactDr Sonali Palkar
Bharati Vidyapeeth DU Medical College Pune
Outcome results
None listed